Clinical trial Recruiting at 2 sites Interventional Ages 18 to 65

How people puff IQOS Iluma i vs IQOS 2.4 and how flavors feel

Official title: Puff Topography and Sensory Effects Across IQOS Device Generations: A Randomized Crossover Study

Run by American University of Beirut Medical Center · NCT07712887 · Data updated 2026-11-12

This study tests how exclusive IQOS users puff the newer Iluma i versus the older 2.4, and whether preferred flavor affects puffing and sensory experience.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorAmerican University of Beirut Medical Center
Academic / other
Locations2 sites (Beirut, Beirut and 1 other locations)
StatusRecruiting
StartedJuly 27, 2026
Main results expectedOctober 1, 2027
Study endsDecember 15, 2027
Registry record updatedJuly 30, 2026
Trial IDNCT07712887 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18-65 who currently use IQOS at least 3 days/week and are generally healthy.

Probably not a fit

Individuals who do not use IQOS or who have conditions requiring nicotine cessation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized crossover study compares puff topography and sensory responses among 50 exclusive IQOS users. Participants use both IQOS Iluma i and IQOS 2.4 across two laboratory visits, with order randomized. Puffing behavior is recorded during ad-libitum use, and chemosensory ratings and subjective effects are collected after each session. The study also compares preferred versus standard flavor to see if flavor shifts influence throat hit, mouthfeel, and satisfaction. Findings will inform device-specific puffing regimens for future emissions assessments.

Why it matters

Potential benefit: If successful, results could improve understanding of real-world puffing patterns for newer IQOS devices and inform more accurate emissions testing.

How similar studies have gone: Previous work has examined puffing with traditional tobacco devices; this study extends methods to newer heated-tobacco devices and flavor conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Current IQOS user (at least 3 days per week in the past 30 days)
* Age 18 to 65 years
* Generally healthy
* Willing to provide informed written consent
* Willing to attend all laboratory visits
* Willing to abstain from all nicotine and tobacco products for at least 12 hours before each visit

Exclusion Criteria:

* Use of any tobacco products other than IQOS in the past 30 days
* Chronic cardiovascular conditions, seizures, or abnormal blood pressure
* Current psychiatric disorder requiring active treatment, including major depressive disorder
* Regular use of prescription medications that may influence cardiovascular function, respiratory function, or nicotine metabolism (excluding vitamins or birth control)
* Use of cocaine, opioids, benzodiazepines, or methamphetamines in the past month
* Marijuana use on more than 15 days per month
* Current pregnancy or breastfeeding
* Plans to quit nicotine or tobacco products within the next 30 days

Where it's running

  • Clinical Aerosol Technology Laboratory (CATLAB), American University of Beirut
    Beirut, Beirut, Lebanon
    Recruiting
  • Clinical Aerosol Technology Laboratory (CATLAB), American University of Beirut
    Beirut, Lebanon
    Recruiting

Study contacts

  • Principal investigator: Soha Talih — American University of Beirut Medical Center
  • Study coordinator: Soha Talih, PhD
  • Email: st38@aub.edu.lb
  • Phone: +961-1-350000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.